Antibody therapy for rheumatoid arthritis.
High-quality monoclonal antibodies (mAbs) with specificity for relevant disease molecules can now be produced in abundance. Anti-tumour necrosis factor-alpha therapies have set a new standard for symptom control in rheumatoid arthritis, and blockade of tumour necrosis factor has the potential to pro...
Prif Awdur: | Taylor, P |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2003
|
Eitemau Tebyg
-
Humanised monoclonal antibody therapy for rheumatoid arthritis.
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
gan: Isaacs, J, et al.
Cyhoeddwyd: (1992) -
Anti-cytokine therapy for rheumatoid arthritis.
gan: Maini, R, et al.
Cyhoeddwyd: (2000) -
Anti-TNFalpha therapy for rheumatoid arthritis: an update.
gan: Taylor, P
Cyhoeddwyd: (2003) -
Antikeratin antibodies in rheumatoid arthritis
gan: J Zabek
Cyhoeddwyd: (2003-02-01)